Organon & Co (OGN)
18.07
-0.71
(-3.78%)
USD |
NYSE |
Nov 01, 16:00
18.02
-0.05
(-0.28%)
After-Hours: 20:00
Organon Total Assets (Quarterly): 12.75B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.75B |
| June 30, 2024 | 12.15B |
| March 31, 2024 | 11.89B |
| December 31, 2023 | 12.06B |
| September 30, 2023 | 11.01B |
| June 30, 2023 | 10.98B |
| March 31, 2023 | 10.76B |
| December 31, 2022 | 10.96B |
| Date | Value |
|---|---|
| September 30, 2022 | 10.44B |
| June 30, 2022 | 10.61B |
| March 31, 2022 | 10.60B |
| December 31, 2021 | 10.68B |
| September 30, 2021 | 11.34B |
| June 30, 2021 | 10.91B |
| March 31, 2021 | 9.642B |
| December 31, 2020 | 10.11B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.642B
Minimum
Mar 2021
12.75B
Maximum
Sep 2024
11.06B
Average
10.93B
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Biomarin Pharmaceutical Inc | 6.851B |
| Cassava Sciences Inc | 243.57M |
| Ligand Pharmaceuticals Inc | 866.40M |
| TG Therapeutics Inc | 401.21M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.26B |
| Shareholders Equity (Quarterly) | 493.00M |
| Debt to Equity Ratio | 17.75 |
| Current Ratio | 1.705 |
| Net Debt Paydown Yield | -0.08% |